PPWP
IBB icon

Proquility Private Wealth Partners’s iShares Biotechnology ETF IBB Stock Holding History

Proquility Private Wealth Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-22,426
Closed -$2.96M – 86
2024
Q4 		$2.96M Sell
22,426
-151
-0.7% -$21.2K 0.95% 36
2024
Q3 		$3.29M Sell
22,577
-2,947
-12% -$426K 1.05% 32
2024
Q2 		$3.5M Buy
25,524
+585
+2% +$78.1K 1.2% 30
2024
Q1 		$3.42M Buy
24,939
+1,360
+6% +$186K 1.17% 30
2023
Q4 		$3.2M Buy
23,579
+1,358
+6% +$166K 1.21% 26
2023
Q3 		$2.72M Buy
22,221
+20
+0.1% +$2.54K 1.11% 29
2023
Q2 		$2.82M Buy
22,201
+122
+0.6% +$15.8K 1.1% 30
2023
Q1 		$2.85M Sell
22,079
-2,284
-9% -$299K 1.13% 28
2022
Q4 		$3.2M Sell
24,363
-123
-0.5% -$15.9K 1.32% 23
2022
Q3 		$2.86M Buy
24,486
+431
+2% +$53.5K 1.32% 25
2022
Q2 		$2.83M Sell
24,055
-267
-1% -$31.7K 1.21% 25
2022
Q1 		$2.66M Buy
24,322
+2,364
+11% +$308K 1.11% 27
2021
Q4 		$2.89M Buy
21,958
+2,552
+13% +$395K 1.02% 30
2021
Q3 		$3.14M Buy
19,406
+516
+3% +$86.8K 1.19% 30
2021
Q2 		$3.09M Sell
18,890
-274
-1% -$42.2K 1.16% 32
2021
Q1 		$2.88M Sell
19,164
-393
-2% -$62.4K 1.15% 30
2020
Q4 		$2.96M Buy
+19,557
New +$2.79M 1.35% 20

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Proquility Private Wealth Partners's IBB Position: Q1 2025 in Review

Proquility Private Wealth Partners sold out of iShares Biotechnology ETF (IBB) in Q1 2025, closing a stake of 22,426 shares — an estimated $2.96M sold.

Proquility Private Wealth Partners first reported a position in IBB in Q4 2020 and held it in 17 quarters. The position peaked at $3.5M in Q2 2024. 831 funds tracked by Wall St. Rank hold IBB as of Q1 2025.

  • Proquility Private Wealth Partners reported no remaining iShares Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
  • Proquility Private Wealth Partners sold 22,426 iShares Biotechnology ETF shares in Q1 2025, an estimated $2.96M.
  • Proquility Private Wealth Partners first reported a position in iShares Biotechnology ETF in Q4 2020 and held it in 17 quarters.
  • Proquility Private Wealth Partners's iShares Biotechnology ETF position peaked at $3.5M in Q2 2024.
  • 831 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.

Based on Proquility Private Wealth Partners's 13F filing for Q1 2025, filed 15 May 2025.